A systematic review and meta-analysis of prognosis and revascularization strategies in chronic limb-threatening ischemia according to the global limb anatomical staging system
Journal of Vascular Surgery · 2026-12 · 84 (6) · 1390-1399.e6
DOI: 10.1016/j.jvs.2026.07.079 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Vascular Surgery, 2026-12. Verfasst von Carlos B Melo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Jundiai Medicine College, São Paulo, Brazil. Electronic address: carlosbmmneto@gmail.com. Hauptthemen laut MEDLINE: Endovascular Procedures, Peripheral Arterial Disease, Ischemia, Vascular Grafting. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: Novo Nordisk Foundation Center for Basic Metabolic Research.
Abstract (Originalsprache)
OBJECTIVE: To perform a systematic review and meta-analysis evaluating the prognostic utility of the Global Limb Anatomical Staging System (GLASS) classification in patients with chronic limb-threatening ischemia, and to determine which intervention, endovascular or open bypass, is associated with superior outcomes in patients classified as GLASS III. METHODS: We conducted a systematic review and meta-analysis using PubMed, Scopus, and Cochrane Central from inception through October 2025. Outcomes compared across GLASS stages included immediate technical success (ITS) of endovascular procedures, overall survival, amputation-free survival, limb salvage, freedom from major adverse limb events (MALE), and limb-based patency (LBP). For patients with GLASS III disease, we directly compared endovascular vs surgical bypass revascularization for overall survival, freedom from MALE, and limb salvage. RESULTS: We included 17 studies in the meta-analysis, comprising 5290 patients and 5492 limbs: 945 (17.2%) GLASS I, 1431 (26.1%) GLASS II, and 3116 (56.7%) GLASS III. Compared with GLASS I, GLASS II presented a significantly higher hazard for LBP failure [hazard ratio (HR), 1.53; 95% confidence interval (CI), 1.06-2.20; P = .032] and major amputation (endovascular only; HR, 1.45; 95% CI, 1.13-1.86). When comparing GLASS III with GLASS I, GLASS III had significantly higher hazard for mortality (HR, 1.28; 95% CI, 1.06-1.56; P = .021), MALE (HR, 1.36; 95% CI, 1.02-1.83; P = .042), and LBP failure (HR, 2.23; 95% CI, 1.56-3.19; P = .003). GLASS I presented a significantly higher ITS rate compared with GLASS II [risk ratio (RR), 1.03; 95% CI, 1.01-1.05; P = .016] and GLASS III (RR, 1.24; 95% CI, 1.09-1.41; P = .005). GLASS II also showed a significantly higher ITS rate compared with GLASS III (RR, 1.20; 95% CI, 1.04-1.38; P = .017). No other comparisons across GLASS stages were statistically significant. Among patients classified as GLASS III, we found an increased hazard of MALE in the endovascular group compared with open bypass surgery (HR, 1.88; 95% CI, 1.35-2.61; P = .015). No significant differences were identified between endovascular and surgical bypass revascularization for other outcomes. CONCLUSIONS: This meta-analysis demonstrates that increasing GLASS anatomical severity is associated with progressively lower ITS following endovascular intervention and increased hazard of LBP failure across all revascularization strategies in patients with chronic limb-threatening ischemia. Patients classified as GLASS I, with low complexity anatomies, had a lower mortality and MALE hazard compared with those with high-complexity disease (GLASS III). Among patients classified as GLASS III, endovascular therapy is associated with an increased hazard for MALE compared with bypass surgery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Jundiai Medicine College, São Paulo, Brazil. Electronic address: carlosbmmneto@gmail.com.
- Department of Medicine, Fluminense Federal University, Rio de Janeiro, Brazil.
- Department of Medicine, Federal University of Pará, Pará, Brazil.
- Department of Medicine, University of Bologna, Bologna, Italy.
- Department of Vascular Surgery, Sydell and Arnold Miller Heart and Vascular Institute, Cleveland Clinic Foundation, Cleveland, OH.
- Bahiana School of Medicine and Public Health, Bahia, Brazil.
Förderung
- Novo Nordisk Foundation Center for Basic Metabolic Research
Zitieren
APA
Melo, C. B., Pimentel-Junior, D., Obara, M. K., Filippini, D., Bertolino, E. P., Fernandez, M. G., Mastra, M. M., McGinigle, K. L., Conte, M. S., & Mulatti, G. C. (2026). A systematic review and meta-analysis of prognosis and revascularization strategies in chronic limb-threatening ischemia according to the global limb anatomical staging system. Journal of Vascular Surgery, 84(6), 1390-1399.e6. https://doi.org/10.1016/j.jvs.2026.07.079
Vancouver
Melo CB, Pimentel-Junior D, Obara MK, Filippini D, Bertolino EP, Fernandez MG, et al. A systematic review and meta-analysis of prognosis and revascularization strategies in chronic limb-threatening ischemia according to the global limb anatomical staging system. Journal of Vascular Surgery. 2026;84(6):1390-1399.e6. doi:10.1016/j.jvs.2026.07.079
BibTeX
@article{Melo2026,
author = {Melo, Carlos B and Pimentel-Junior, Dilson and Obara, Mariana K and Filippini, Denise and Bertolino, Enrico P and Fernandez, Miguel Godeiro and Mastra, Milena Monteiro and McGinigle, Katharine L and Conte, Michael S and Mulatti, Grace Carvajal},
title = {A systematic review and meta-analysis of prognosis and revascularization strategies in chronic limb-threatening ischemia according to the global limb anatomical staging system},
journal = {Journal of Vascular Surgery},
year = {2026},
volume = {84},
number = {6},
pages = {1390--1399.e6},
doi = {10.1016/j.jvs.2026.07.079}
}
EUVIMED